KemPharm Prepares for Secondary Offering
KemPharm expects to price its 3 million shares around last Thursday's closing price of $18.88, which would value the entire secondary offering at up to more than $65 million.
KemPharm expects to price its 3 million shares around last Thursday's closing price of $18.88, which would value the entire secondary offering at up to more than $65 million.
24/7 Wall St. has put together a preview of the two major companies reporting their quarterly results this coming week: Nike and Micron Technology.
24/7 Wall St. has tracked four companies in which shareholders were destroyed last week. Many of these companies have seen their markets caps drop sharply.
24/7 Wall Street has picked out a few retailers that have whiffed this season and contributed to the sliding broad markets.
The SEC has announced that two JPMorgan wealth management subsidiaries have agreed to pay $267 million and admit wrongdoing to settle charges regarding a failure to disclose conflicts of interest to clients.
SecureWorks has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
ReachLocal raised its outlook for fourth-quarter 2015 adjusted EBITDA and announced a series of strategic actions to improve adjusted EBITDA and its liquidity position in order to provide a foundation for future growth.
CarMax reported disappointing fiscal third-quarter financial results before the markets opened on Friday.
Despite having a dismal year, Micron Technology might be turning things around with its most recent acquisition.
Intercept Pharmaceuticals announced that the FDA has extended the PDUFA date for its Priority Review of obeticholic acid in primary biliary cholangitis.
BlackBerry reported better-than-expected fiscal third-quarter financial results before the markets opened on Friday.
Red Hat reported its fiscal third-quarter financial results after the markets closed on Thursday.
BlackBerry is scheduled to report its fiscal third-quarter financial results before the markets open on Friday.
The SEC has charged Martin Shkreli, former CEO of pharmaceutical company Retrophin, with committing fraud during a five-year period when he also was working as a hedge fund manager.
The SEC barred hedge fund adviser Owen Li from the securities industry for making a series of false statements to investors and ultimately precipitating a fund's collapse.
Pandora Media saw its shares shoot up early Thursday,following the announcement by the Copyright Royalty Board regarding the rates online streamers might pay for content.
Pier 1 Imports reported mixed fiscal third-quarter financial results Thursday after the markets closed on Wednesday.
In its latest SEC filing concerning its IPO, Guatemalan financial services provider Bicapital described its finances.
As quickly as KaloBios Pharmaceuticals shares shot up, they are dropping after its newly named chief executive, Martin Shkreli, was arrested.
Oracle reported better-than-expected fiscal second-quarter financial results after the markets closed on Wednesday.